Finance & Markets

SpaceX bolsters the case against quarterly earnings

What has happened to the finances of Elon Musk’s rocket maker over the past three months is pretty irrelevant

ft.com ·11h ago

SpaceX bolsters the case against quarterly earnings

We haven't written up this one. Financial Times has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Elon Musk delivers ‘totally nuts’ plans for moon robots and insists $1 trillion revenue target will hit but capex tanks SpaceX on debut earnings fortune.com
SpaceX extends decline to 11% on lockup expiration and capex spending fears coindesk.com
SpaceX is falling after posting first earnings report since IPO. What the biggest Wall Street firms are saying cnbc.com

Read the original at ft.com →

More in Finance & Markets

Duolingo users are fed up with random strangers cluttering their feeds

Finance & Markets

Duolingo users are fed up with random strangers cluttering their feeds

Unwanted activity updates are burying friend milestones, driving learners to manually block unknown accounts daily.

31m ago ·androidauthority.com

Finance & Markets

Bharat Taxi won't replace Ola, Uber: Amit Shah explains its objectives, funding, safety measures and expansion plans

Bharat Taxi, the cooperative-based ride-hailing platform, is not intended to replace private app-based taxi aggregators, the government clarified.

35m ago ·livemint.com

Editorial illustration

Finance & Markets

Dow rallies 600 points to fresh record on earnings strength, hope around U.S.-Iran deal: Live updates

36m ago ·cnbc.com

Abu Dhabi's IHC posts more than 200% jump in second quarter profit to $3.5bn

Finance & Markets

Abu Dhabi's IHC posts more than 200% jump in second quarter profit to $3.5bn

Abu Dhabi’s International Holding Company posted a 220 per cent surge in second-quarter profit to Dh12.8 billion ($3.5 billion), boosted by a sharp increase in energy and mining revenue as the…

41m ago ·thenationalnews.com

Finance & Markets

Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch

Some analysts see warning signs in crucial drug launches from Gilead and Merck, while an important trial readout could change Pfizer’s growth trajectory.

43m ago ·biopharmadive.com

Kwadaso MCE cuts sod for construction of 24-Hour Economy Market project

Finance & Markets

Kwadaso MCE cuts sod for construction of 24-Hour Economy Market project

The Municipal Chief Executive for Kwadaso, Eric Assibey, has cut the sod for the construction of the municipality’s 24-Hour Economy Market, describing it as a major step toward implementing the…

50m ago ·myjoyonline.com